The in Vitro Protective Effects of Curcumin and Demethoxycurcumin in Curcuma Longa Extract on Advanced Glycation End Products-Induced Mesangial Cell Apoptosis and Oxidative Stress

Ji-ping Liu,Liang Feng,Mao-mao Zhu,Ru-shang Wang,Ming-hua Zhang,Shao-ying Hu,Xiao-bin Jia,Jin-jie Wu
DOI: https://doi.org/10.1055/s-0032-1315257
IF: 3.007
2012-01-01
Planta Medica
Abstract:Curcuma longa L. (CLL), a traditional herbal medicine, has been widely used for the prevention of diabetic vascular complications in recent years. However, the protective effects of curcuminoids in CLL on the AGEs-induced damage to mesangial cell are not fully understood. In this present study, dihydroethidium, superoxide dismutase kit, malondialdehyde kit, and acridine orange/ethidium bromide staining methods were used to evaluate the activities of curcumin and demethoxycurcumin (10(-11)-10(-9) M) on AGEs-induced oxidative stress and apoptosis, which were associated with the damage to mesangial cell. The results showed that these two compounds could significantly restore advanced glycation end products (AGEs)-induced apoptosis to normal levels (IC50 = 3.874 x 10(-11) M for curcumin and IC50 = 6.085 x 10(-11) M for demethoxycurcumin) and reduce remarkably reactive oxygen species generation in mesangial cell. Furthermore, curcumin and demethoxycurcumin dramatically elevated AGEs-decreased superoxide dismutase activity while significantly reducing AGEs-increased malondialdehyde content in cell culture supernatant. Our results suggest that both curcumin and demethoxycurcumin have a significant protective potential to the prevention of diabetic nephropathy.
What problem does this paper attempt to address?